Skip to main content
Log in

Treatment options for patients with severe rheumatoid arthritis are gradually increasing

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lacki JK. Management of the patient with severe refractory rheumatoid arthritis. Are the newer treatment options worth considering? Biodrugs 2000 Jun; 13(6): 425–35

    Article  PubMed  CAS  Google Scholar 

  2. Prakash A, Jarvis B. Leflumomide. A review of its use in active rheumatoid arthritis. Drugs 1999 Dec; 58(6): 1137–64

    Article  PubMed  CAS  Google Scholar 

  3. Jarvis B, Faulds D. Etanercept. A review of its use in rheumatoid arthritis. Drugs 1999 Jun; 57(6): 945–66

    Article  PubMed  CAS  Google Scholar 

  4. Markham A, Lamb HM. Infliximab. A review of its use in the management of rheumatoid arthritis. Drugs 2000 Jun; 59(6): 1341–59

    Article  PubMed  CAS  Google Scholar 

  5. McQueen FM, Stewart N, Crabbe J, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosion at four months after symptom onset. Ann Rheum Dis 1998; 57: 350–6

    Article  PubMed  CAS  Google Scholar 

  6. van der Heijde DMFM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995; 34 Suppl.2: 59–73

    Google Scholar 

  7. Pincus T. Clinical observations often provide more accurate information concerning the long-term natural history and results than structured research studies. Rheumatol Eur 1995; 2 Suppl.: 179–84

    Google Scholar 

  8. Pincus T, O’Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventative strategy. Ann Intern Med 1999 Nov 16; 131: 768–74

    PubMed  CAS  Google Scholar 

  9. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1995; 38: 727–35

    Article  PubMed  CAS  Google Scholar 

  10. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996: 39: 713–22

    Article  Google Scholar 

  11. PDR 55th ed. Montvale NJ: Medical Economics, 2001 pp. 685-9, 828-9, 1085-88, 1551-54 and PDR 53rd ed. 1999 pp. 1397-1401

  12. Arava: steps taken after granting marketing authorisation [online]. European Agency for the Evaluation of Medicinal Products. May 2001. Available from: URL: http://www.eudra.org/humandocs/Humans/EPAR/Arava/Arava.htm

  13. Smolen JS, Steiner G, Breedveld FC, et al. Anti-TNFα therapy and drug induced lupus-like syndrome [abstract no. 906]. Ann Rheum Dis 1999 Jun 6; EULAR Suppl.: 217

    Google Scholar 

  14. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of Etanercept, a recombinant tumor necrosis factor receptor. Fcfusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999 Jan 28; 340: 253–9

    Article  PubMed  CAS  Google Scholar 

  15. Maini R, St Clair EW, Breedveld FC, et al. Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999 Dec 4; 354: 1923–9

    Article  Google Scholar 

  16. Centocor Inc. X-ray study suggests Remicade™ stops progression of rheumatoid arthritis [media release]; 15 Nov 1999 [3 pages]

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treatment options for patients with severe rheumatoid arthritis are gradually increasing. Drugs Ther. Perspect 17, 4–8 (2001). https://doi.org/10.2165/00042310-200117120-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117120-00002

Keywords

Navigation